UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 40

Sortiert nach

The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia

Nature genetics, 2015-06, Vol.47 (6), p.672-676

2015

Volltextzugriff (PDF)

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

Atherosclerosis, 2009-02, Vol.202 (2), p.382-393

2009

Volltextzugriff (PDF)

Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation

Haematologica (Roma), 2024-03, Vol.109 (3), p.725

2024

Volltextzugriff (PDF)

The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia

PloS one, 2016-09, Vol.11 (9), p.e0162638-e0162638

2016

Volltextzugriff (PDF)

α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report

Arteriosclerosis, thrombosis, and vascular biology, 2014-12, Vol.34 (12), p.2632

2014

Volltextzugriff (PDF)

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

European journal of haematology, 2017-01, Vol.98 (1), p.26-37

2017

Volltextzugriff (PDF)

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

Haematologica (Roma), 2018-02, Vol.103 (2), p.246

2018

Volltextzugriff (PDF)

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children

Cancer medicine (Malden, MA), 2021-06, Vol.10 (12), p.3997-4003

2021

Volltextzugriff (PDF)

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia

Haematologica (Roma), 2016-01, Vol.101 (1), p.e20

2016

Volltextzugriff (PDF)

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Leukemia, 2022-07, Vol.36 (7), p.1703-1719

2022

Volltextzugriff (PDF)

Infection with Neoehrlichia mikurensis promotes the development of malignant B‐cell lymphomas

British journal of haematology, 2023-05, Vol.201 (3), p.480-488

2023

Volltextzugriff (PDF)

Natural antibodies in murine atherosclerosis

Current drug targets, 2008-03, Vol.9 (3), p.190

2008

Volltextzugriff (PDF)

Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia

European journal of human genetics : EJHG, 2023-08, Vol.31 (8), p.887-894

2023

Volltextzugriff (PDF)

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells

The Journal of experimental medicine, 2022-09, Vol.219 (9)

2022

Volltextzugriff (PDF)

Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study

British journal of haematology, 2016-08, Vol.174 (4), p.600-609

2016

Volltextzugriff (PDF)

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice

Oncogene, 2017-03, Vol.36 (11), p.1516-1524

2017

Volltextzugriff (PDF)

Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection

BMC infectious diseases, 2014-03, Vol.14 (1), p.143-143, Article 143

2014

Volltextzugriff (PDF)

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Journal of internal medicine, 2022-12, Vol.292 (6), p.925-940

2022

Volltextzugriff (PDF)

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

British journal of haematology, 2020-07, Vol.190 (2), p.198-208

2020

Volltextzugriff (PDF)

Early hematopoiesis in multiple sclerosis patients

Journal of neuroimmunology, 2016-10, Vol.299, p.158-163

2016

Volltextzugriff (PDF)

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

European journal of cancer (1990), 2020-09, Vol.136, p.116-129

2020

Volltextzugriff (PDF)

MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development

Experimental hematology, 2016-12, Vol.44 (12), p.1166-1171

2016

Volltextzugriff (PDF)

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6–RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

International journal of laboratory hematology, 2017-04, Vol.39 (2), p.121-128

2017

Volltextzugriff (PDF)

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.409-417

2019

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Aktive Filter

ThemaHumans

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(40)

Sprache

Englisch
(40)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The genomic landscape of high hyperdiploid childhood acute lymphoblastic leukemia

Induction of proinflammatory cytokines by long-chain saturated fatty acids in human macrophages

Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation

The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

RAG1 co‐expression signature identifies ETV6‐RUNX1‐like B‐cell precursor acute lymphoblastic leukemia in children

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Infection with Neoehrlichia mikurensis promotes the development of malignant B‐cell lymphomas

Natural antibodies in murine atherosclerosis

Ribonuclease inhibitor 1 (RNH1) deficiency cause congenital cataracts and global developmental delay with infection-induced psychomotor regression and anemia

Human CD38 regulates B cell antigen receptor dynamic organization in normal and malignant B cells

Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice

Reduced IgM levels and elevated IgG levels against oxidized low-density lipoproteins in HIV-1 infection

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

Early hematopoiesis in multiple sclerosis patients

Paediatric Strategy Forum for medicinal product development for acute myeloid leukaemia in children and adolescents: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration

MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6–RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

Aktive Filter

Suchergebnisse filtern